Christina Ising

University of Cologne — Germany

Medicine · Health Sciences

16h-index3.0kcitations31works49.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(15), Neuroinflammation and Neurodegeneration Mechanisms(13), Renal Diseases and Glomerulopathies(8), Genetic and Kidney Cyst Diseases(6), Chronic Kidney Disease and Diabetes(5)

Publications31 total

Enhancing Tyro3 signaling ameliorates IL-1β production through STAT1 in Alzheimer's disease models
Journal of Leukocyte Biology·2025· 1 cited
Axonal degeneration and retinal neurovascular dysfunction in the TgF344-AD rat model of Alzheimer's disease
Journal of Alzheimer s Disease·2025· 2 cited
Wie Tau die Reaktionen von Mikroglia in Tauopathien beeinflusst
BIOspektrum·2025Open Access
Enhancing Tyro3 signaling ameliorates IL-1β production through STAT1 in Alzheimer's disease models.
DZNE Pub·2025
Neuroinflammation in Alzheimer disease
Nature reviews. Immunology·2024· 289 citedOpen Access
The putative contribution of cellular senescence to driving tauopathies
Trends in Immunology·2024· 4 cited
Characterizing microglial senescence: Tau as a key player
Journal of Neurochemistry·2023· 29 citedOpen Access
Chronic inflammation: a potential target in tauopathies
The Lancet Neurology·2023· 7 cited
Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer’s disease: results from the DELCODE study
Alzheimer s Research & Therapy·2023· 45 citedOpen Access
Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer’s disease
Neuron·2022· 62 cited
Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology
The EMBO Journal·2021· 124 citedOpen Access
Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms
Neuron·2021· 125 citedOpen Access
Innate immune activation of the NLRP3 inflammasome pathway drives tau pathology
Alzheimer s & Dementia·2020
Overexpressing Low-Density Lipoprotein Receptor Reduces Tau-Associated Neurodegeneration Via ApoE-Dependent and Independent Mechanisms
SSRN Electronic Journal·2020· 1 citedOpen Access
NLRP3 inflammasome activation drives tau pathology
Nature·2019· 1.4k citedOpen Access
Anaerobic Glycolysis Maintains the Glomerular Filtration Barrier Independent of Mitochondrial Metabolism and Dynamics
Cell Reports·2019· 160 citedOpen Access
Partizipative Forschung : Teilhabeerfahrungen aus Forschungs- und Praxisperspektive
2019· 1 cited
Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration
Cell Death and Disease·2018· 133 citedOpen Access
Correction: AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy
The Journal of Experimental Medicine·2017· 5 citedOpen Access
AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy
The Journal of Experimental Medicine·2017· 56 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Michael T. Heneka(10), Paul T. Brinkkoetter(10), Thomas Benzing(9), Bernhard Schermer(8), Róisín M. McManus(7), Eicke Latz(7), Frederic Brosseron(6), Henning Hagmann(6), Sebastian Brähler(6), Francesco Santarelli(5), Alfredo Ramı́rez(5), Martin Höhne(5), Hannah Scheiblich(4), Susanne V. Schmidt(4), Stephanie Schwartz(4), Angelika Griep(4), Sybille Koehler(4), Javier Remolina Serrano(4), David M. Holtzman(4), Kishore Aravind Ravichandran(4)